MU Stock Cash Flow Statements

Micron Technology . Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Micron Technology . Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-05-29	2025-02-27	2024-11-28	2024-08-29	2024-05-30	2024-02-29	2023-11-30	2023-08-31	2023-06-01	2023-03-02	2022-12-01	2022-09-01	2022-06-02	2022-03-03	2021-12-02	2021-09-02	2021-06-03	2021-03-04	2020-12-03	2020-09-03	2020-05-28	2020-02-27	2019-11-28	2019-08-29	2019-05-30	2019-02-28	2018-11-29	2018-08-30	2018-05-31	2018-03-01	2017-11-30	2014-08-28	2014-05-29	2014-02-27	2013-11-28

cash flows from operating activities
net income	1,885,000,000	1,583,000,000	1,870,000,000	887,000,000	332,000,000	793,000,000	-1,234,000,000	-1,430,000,000	-1,896,000,000	-2,312,000,000	-195,000,000	1,492,000,000	2,626,000,000	2,263,000,000	2,306,000,000	2,720,000,000	1,735,000,000	603,000,000	803,000,000	990,000,000	805,000,000	407,000,000	508,000,000	586,000,000	851,000,000	1,625,000,000	3,296,000,000	4,326,000,000	3,823,000,000	3,311,000,000	2,678,000,000	1,151,000,000	806,000,000	741,000,000	381,000,000
adjustments to reconcile net income to net cash from operating activities:
depreciation expense and amortization of intangible assets	2,094,000,000	2,079,000,000	2,030,000,000	1,986,000,000	1,955,000,000	1,924,000,000	1,915,000,000	1,937,000,000	1,956,000,000	1,942,000,000	1,921,000,000	1,882,000,000	1,821,000,000	1,742,000,000	1,671,000,000	1,621,000,000	1,557,000,000	1,549,000,000	1,487,000,000	1,567,000,000	1,422,000,000	1,365,000,000	1,296,000,000	1,416,000,000	1,360,000,000	1,313,000,000	1,335,000,000	1,285,000,000	1,233,000,000	1,151,000,000	1,090,000,000	553,000,000	542,000,000	517,000,000	491,000,000
stock-based compensation	253,000,000	249,000,000	220,000,000	213,000,000	219,000,000	213,000,000	188,000,000	148,000,000	145,000,000	157,000,000	146,000,000	136,000,000	131,000,000	129,000,000	118,000,000	93,000,000	96,000,000	97,000,000	92,000,000	89,000,000	82,000,000	85,000,000	72,000,000	67,000,000	58,000,000	57,000,000	61,000,000	47,000,000	48,000,000	52,000,000	51,000,000	34,000,000	32,000,000	27,000,000	22,000,000
change in operating assets and liabilities:
receivables	-461,000,000	1,155,000,000	-817,000,000	-1,019,000,000	-803,000,000	-1,258,000,000	-501,000,000	35,000,000	-182,000,000	1,068,000,000	1,842,000,000	1,096,000,000	-862,000,000	-111,000,000	67,000,000	-1,106,000,000	-873,000,000	282,000,000	251,000,000	-262,000,000	-565,000,000	312,000,000	-208,000,000	58,000,000	1,171,000,000	1,013,000,000	189,000,000	-557,000,000	-547,000,000	-509,000,000	-121,000,000	-188,000,000	128,000,000	36,000,000	-494,000,000
inventories	280,000,000	-302,000,000	170,000,000	-363,000,000	-68,000,000	-168,000,000	111,000,000	-149,000,000	-510,000,000	-1,199,000,000	-1,697,000,000	-1,033,000,000	-246,000,000	-556,000,000	-344,000,000	52,000,000	185,000,000	543,000,000	86,000,000	-203,000,000	-196,000,000	-265,000,000	175,000,000	-213,000,000	-515,000,000	-514,000,000	-286,000,000	-226,000,000	-184,000,000	-25,000,000	-37,000,000	77,000,000	-71,000,000	-2,000,000	190,000,000
other current assets	-2,000,000				364,000,000
accounts payable and accrued expenses	752,000,000	-473,000,000	-241,000,000	1,069,000,000	273,000,000	302,000,000	271,000,000	-340,000,000	31,000,000	-739,000,000	-1,056,000,000	362,000,000	275,000,000	149,000,000	-42,000,000	519,000,000	468,000,000	-24,000,000	-753,000,000	25,000,000	443,000,000	79,000,000	178,000,000	529,000,000	-377,000,000	-280,000,000	-46,000,000	511,000,000	-55,000,000	354,000,000	-261,000,000	96,000,000	86,000,000	81,000,000	408,000,000
other current liabilities	-360,000,000	-160,000,000	-161,000,000	220,000,000	63,000,000	127,000,000	579,000,000
other	168,000,000	15,000,000	173,000,000	-23,000,000	147,000,000	85,000,000	72,000,000	-64,000,000	79,000,000	-4,000,000	-18,000,000	-159,000,000	50,000,000	66,000,000	25,000,000	-75,000,000	21,000,000	-14,000,000	18,000,000	6,000,000	38,000,000	-7,000,000	3,000,000	-185,000,000	-39,000,000	-1,000,000	65,000,000	-204,000,000	-65,000,000	-2,000,000	12,000,000	-155,000,000	59,000,000	-57,000,000	182,000,000
net cash from operating activities	4,609,000,000	3,942,000,000	3,244,000,000	3,405,000,000	2,482,000,000	1,219,000,000	1,401,000,000	249,000,000	24,000,000	343,000,000	943,000,000	3,777,000,000	3,838,000,000	3,628,000,000	3,938,000,000	3,884,000,000	3,560,000,000	3,057,000,000	1,967,000,000	2,271,000,000	2,023,000,000	2,001,000,000	2,011,000,000	2,233,000,000	2,711,000,000	3,435,000,000	4,810,000,000	5,155,000,000	4,261,000,000	4,348,000,000	3,636,000,000	1,347,000,000	1,455,000,000	1,390,000,000	1,507,000,000
capex	-2,938,000,000	-4,055,000,000	-3,206,000,000	-3,120,000,000	-2,086,000,000	-1,384,000,000	-1,796,000,000	-1,461,000,000	-1,561,000,000	-2,205,000,000	-2,449,000,000	-3,613,000,000	-2,578,000,000	-2,611,000,000	-3,265,000,000	-2,015,000,000	-2,259,000,000	-3,018,000,000	-2,738,000,000	-2,280,000,000	-1,944,000,000	-2,056,000,000	-1,943,000,000	-2,028,000,000	-2,403,000,000	-2,649,000,000	-2,700,000,000	-2,251,000,000	-2,411,000,000	-2,261,000,000	-1,956,000,000	-1,140,000,000	-487,000,000	-505,000,000	-526,000,000
free cash flows	1,671,000,000	-113,000,000	38,000,000	285,000,000	396,000,000	-165,000,000	-395,000,000	-1,212,000,000	-1,537,000,000	-1,862,000,000	-1,506,000,000	164,000,000	1,260,000,000	1,017,000,000	673,000,000	1,869,000,000	1,301,000,000	39,000,000	-771,000,000	-9,000,000	79,000,000	-55,000,000	68,000,000	205,000,000	308,000,000	786,000,000	2,110,000,000	2,904,000,000	1,850,000,000	2,087,000,000	1,680,000,000	207,000,000	968,000,000	885,000,000	981,000,000
cash flows from investing activities
expenditures for property, plant, and equipment	-2,938,000,000	-4,055,000,000	-3,206,000,000	-3,120,000,000	-2,086,000,000	-1,384,000,000	-1,796,000,000	-1,461,000,000	-1,561,000,000	-2,205,000,000	-2,449,000,000	-3,613,000,000	-2,578,000,000	-2,611,000,000	-3,265,000,000	-2,015,000,000	-2,259,000,000	-3,018,000,000	-2,738,000,000	-2,280,000,000	-1,944,000,000	-2,056,000,000	-1,943,000,000	-2,028,000,000	-2,403,000,000	-2,649,000,000	-2,700,000,000	-2,251,000,000	-2,411,000,000	-2,261,000,000	-1,956,000,000
purchases of available-for-sale securities	-387,000,000	-439,000,000	-377,000,000	-889,000,000	-645,000,000	-266,000,000	-199,000,000	-227,000,000	-203,000,000	-203,000,000	-90,000,000	-411,000,000	-437,000,000	-394,000,000	-528,000,000	-1,244,000,000	-570,000,000	-347,000,000	-1,002,000,000	-1,064,000,000	-227,000,000	-159,000,000	-407,000,000	-404,000,000	-1,248,000,000	-519,000,000	-2,047,000,000	-154,000,000	-104,000,000	-316,000,000	-186,000,000	-588,000,000	-116,000,000	-163,000,000	-196,000,000
proceeds from government incentives	266,000,000	963,000,000	65,000,000	48,000,000	33,000,000	149,000,000	85,000,000	462,000,000	184,000,000	62,000,000	2,000,000	11,000,000	38,000,000	11,000,000	55,000,000	160,000,000	159,000,000	136,000,000	40,000,000	122,000,000	35,000,000	83,000,000	22,000,000	80,000,000	213,000,000	219,000,000	236,000,000
proceeds from maturities and sales of available-for-sale securities	375,000,000	446,000,000	428,000,000	361,000,000	707,000,000	352,000,000	374,000,000
net cash from investing activities	-2,589,000,000	-3,152,000,000	-3,148,000,000	-3,598,000,000	-2,002,000,000	-1,151,000,000	-1,558,000,000	-830,000,000	-1,180,000,000	-1,915,000,000	-2,266,000,000	-3,824,000,000	-2,585,000,000	-2,691,000,000	-2,485,000,000	-2,534,000,000	-2,081,000,000	-2,556,000,000	-3,418,000,000	-2,738,000,000	-1,952,000,000	-1,710,000,000	-1,189,000,000	-1,100,000,000	-2,066,000,000	-2,492,000,000	-4,427,000,000	-2,129,000,000	-2,244,000,000	-2,409,000,000	-1,434,000,000	-1,530,000,000	-472,000,000	-472,000,000	21,000,000
cash flows from financing activities
proceeds from issuance of debt	1,748,000,000			0	0			0	1,495,000,000	1,872,000,000	3,349,000,000	0	0	0	2,000,000,000	0				0	3,750,000,000	0	1,250,000,000	1,750,000,000	0			40,000,000	319,000,000	500,000,000	150,000,000	1,150,000,000	0
repayments of debt	-978,000,000	-2,542,000,000	-84,000,000	-81,000,000	-715,000,000	-1,048,000,000	-53,000,000	-55,000,000	-653,000,000	-33,000,000	-20,000,000	-24,000,000	-27,000,000	-32,000,000	-1,949,000,000	-176,000,000	-1,241,000,000	-19,000,000	-84,000,000	-80,000,000	-2,610,000,000	-261,000,000	-1,415,000,000	-964,000,000	-1,671,000,000	-128,000,000	-577,000,000	-3,427,000,000	-3,388,000,000	-635,000,000	-2,744,000,000	-709,000,000	-1,147,000,000	-1,250,000,000	-737,000,000
payments of dividends to shareholders	-131,000,000	-130,000,000	-131,000,000	-129,000,000	-128,000,000	-127,000,000	-129,000,000	-126,000,000	-126,000,000	-126,000,000	-126,000,000	-126,000,000	-111,000,000	-112,000,000	-112,000,000
payments on equipment purchase contracts				-22,000,000	-45,000,000	-26,000,000	-56,000,000	-26,000,000	-36,000,000	-29,000,000	-47,000,000	-9,000,000	-27,000,000	-27,000,000	-78,000,000	-156,000,000	-16,000,000	-26,000,000	-97,000,000	-14,000,000	-20,000,000	-18,000,000	-11,000,000	-21,000,000	-17,000,000	-17,000,000	-20,000,000	-36,000,000	-17,000,000	-20,000,000	-133,000,000	-187,000,000	-89,000,000	-60,000,000	-143,000,000
net cash from financing activities	540,000,000	96,000,000	-422,000,000	-474,000,000	-910,000,000	-106,000,000	-352,000,000	-112,000,000	661,000,000	1,802,000,000	2,632,000,000	-840,000,000	-1,161,000,000	-466,000,000	-513,000,000	-1,344,000,000	-228,000,000	5,000,000	-214,000,000	-182,000,000	1,072,000,000	-215,000,000	-992,000,000	892,000,000	-1,847,000,000	952,000,000	-2,435,000,000	-3,333,000,000	-3,023,000,000	-138,000,000	-1,282,000,000	286,000,000	-1,228,000,000	-271,000,000	-735,000,000
effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash	46,000,000	-20,000,000	-29,000,000	55,000,000	-7,000,000	-7,000,000	-1,000,000	-21,000,000	-22,000,000	15,000,000	-6,000,000	-35,000,000	-55,000,000	-10,000,000	-6,000,000	-3,000,000	1,000,000	16,000,000	27,000,000	19,000,000	6,000,000	0	-14,000,000	20,000,000	7,000,000	9,000,000	-10,000,000	-33,000,000	-8,000,000	10,000,000	-6,000,000
net increase in cash, cash equivalents, and restricted cash	2,606,000,000	866,000,000	-355,000,000	-612,000,000	-437,000,000	-45,000,000	-510,000,000	-714,000,000	-517,000,000	245,000,000	1,303,000,000	-922,000,000	37,000,000	461,000,000	934,000,000	3,000,000	1,252,000,000	522,000,000	-1,638,000,000	-630,000,000				2,045,000,000	-1,195,000,000	1,904,000,000	-2,062,000,000	-340,000,000	-1,014,000,000	1,811,000,000	914,000,000
cash, cash equivalents, and restricted cash at beginning of period	0	0	7,052,000,000	0	0	0	8,656,000,000	0	0	0	8,339,000,000	0	0	0	7,829,000,000	0	0	0	7,690,000,000	0	0	0	7,279,000,000	0	0	0	6,587,000,000	0	0	0	5,216,000,000
cash, cash equivalents, and restricted cash at end of period	2,606,000,000	866,000,000	6,697,000,000	-612,000,000	-437,000,000	-45,000,000	8,146,000,000	-714,000,000	-517,000,000	245,000,000	9,642,000,000	-922,000,000	37,000,000	461,000,000	8,763,000,000	3,000,000	1,252,000,000	522,000,000	6,052,000,000	-630,000,000	1,149,000,000	76,000,000	7,095,000,000	2,045,000,000	-1,195,000,000	1,904,000,000	4,525,000,000	-340,000,000	-1,014,000,000	1,811,000,000	6,130,000,000
provision to write down inventories to net realizable value								0
goodwill impairment
proceeds from sale of lehi, utah fab												0	-5,000,000	0	893,000,000
repurchases of common stock - repurchase program								0	0	0	-425,000,000	-784,000,000	-981,000,000	-408,000,000	-259,000,000
supplemental disclosures
income taxes paid
interest paid, net of amounts capitalized
noncash equipment acquisitions on contracts payable
provision to write-down inventories to net realizable value
restructure and asset impairments												1,000,000				8,000,000																			-8,000,000
loss on debt repurchases and conversions																														23,000,000	195,000,000
proceeds from maturities of available-for-sale securities								396,000,000	405,000,000	407,000,000	358,000,000	357,000,000	333,000,000	318,000,000	313,000,000	226,000,000	278,000,000	530,000,000	216,000,000	178,000,000	113,000,000	360,000,000	163,000,000	915,000,000	235,000,000	331,000,000	60,000,000	101,000,000	81,000,000	53,000,000	85,000,000
proceeds from sales of available-for-sale securities								3,000,000	14,000,000	4,000,000	4,000,000	36,000,000	86,000,000	48,000,000	124,000,000	383,000,000	295,000,000	133,000,000	45,000,000	301,000,000	98,000,000	71,000,000	988,000,000	233,000,000	1,111,000,000	83,000,000	77,000,000	35,000,000	7,000,000	8,000,000	554,000,000
(gain) loss on debt repurchases
(gain) loss on debt repurchases and conversions												0	0	0	83,000,000
repurchases of common stock - withholdings on employee equity awards												-9,000,000	-4,000,000	-10,000,000	-102,000,000
acquisition of noncontrolling interest in imft																				0	0	0	-744,000,000
adjustments to reconcile net income to net cash from operating activities
change in operating assets and liabilities
deferred income taxes															54,000,000	44,000,000	-83,000,000	13,000,000	-24,000,000	53,000,000	-12,000,000	19,000,000	19,000,000	-45,000,000				-49,000,000	46,000,000			-116,000,000	57,000,000	68,000,000	59,000,000
amortization of debt discount and other costs																8,000,000	7,000,000	8,000,000	7,000,000	6,000,000	4,000,000	6,000,000	10,000,000	10,000,000	10,000,000	11,000,000	18,000,000	23,000,000	23,000,000	26,000,000	29,000,000	37,000,000	36,000,000	44,000,000	50,000,000
(gains) losses on debt prepayments, repurchases, and conversions
payments to acquire treasury stock																				-48,000,000	-44,000,000	-70,000,000	-89,000,000	-2,000,000	-159,000,000	-732,000,000	-1,836,000,000
noncash equipment acquisitions on contracts payable and finance leases
(gain) loss on debt prepayments, repurchases, and conversions																											-14,000,000
proceeds from issuance of stock																								67,000,000	20,000,000	77,000,000	15,000,000	19,000,000	82,000,000	82,000,000	1,472,000,000
(gains) losses on debt prepayments and conversions
net decrease in cash, cash equivalents, and restricted cash																						76,000,000	-184,000,000
gain on debt prepayments, repurchases, and conversions																							-42,000,000
loss on debt prepayments, repurchases, and conversions																								10,000,000	317,000,000			-1,000,000
gain on remeasurement of previously-held equity interest in inotera
payments attributed to intercompany balances with inotera
acquisition of inotera
noncash investing and financing activity
equipment acquisitions on contracts payable and capital leases																																293,000,000	86,000,000	128,000,000	80,000,000
deferred tax assets																										128,000,000	192,000,000
payments to settle hedging activities																												-101,000,000	-56,000,000	-11,000,000	-17,000,000	-1,000,000
proceeds from settlement of hedging activities																												12,000,000	40,000,000	83,000,000	28,000,000
proceeds from equipment sale-leaseback transactions																																0	0	0	14,000,000
other noncurrent liabilities
equity in net (income) loss of equity method investees																																-119,000,000	-135,000,000	-134,000,000	-86,000,000
deferred income
proceeds from sales and maturities of available-for-sale securities																																115,000,000	122,000,000	158,000,000	162,000,000
proceeds from issuance of stock under equity plans
cash paid to acquire treasury stock
loss on restructure of debt																																13,000,000	16,000,000
(gain) income from currency hedges
equity in net income of equity method investees
gain from inotera issuance of shares
gain from disposition of interest in aptina
increase in restricted cash
cash received from disposition of interest in aptina
contributions from noncontrolling interests
acquisition of noncontrolling interests
effect of changes in currency exchange rates on cash and equivalents
net increase in cash and equivalents																																88,000,000	-243,000,000	651,000,000	774,000,000
cash and equivalents at beginning of period																																0	0	0	2,880,000,000
cash and equivalents at end of period																																88,000,000	-243,000,000	651,000,000	3,654,000,000
noncash investing and financing activities
exchange of convertible notes																																0	0	0	756,000,000
acquisition of noncontrolling interest																																0	0
•
noncash restructure and asset impairment
(gain) on mmj acquisition
expenditures for property, plant and equipment																																-1,140,000,000	-487,000,000	-505,000,000	-526,000,000
income taxes refunded (paid)
noncash investing and financing activities:
assets acquired and liabilities assumed:
cash and equivalents
restricted cash
property, plant and equipment
equity method investment
intangible assets
other noncurrent assets
current portion of long-term debt
long-term debt
total net assets acquired
noncontrolling interest in mmj
consideration
preliminary gain on acquisition recognized in 2013
adjustment for preliminary pre-petition liabilities
final gain on acquisition
(gains) losses from currency hedges																																8,000,000	-2,000,000	7,000,000	14,000,000
noncash restructure and asset impairments																																0
additions to equity method investments
decrease in restricted cash																																-23,000,000	3,000,000	0	556,000,000
cash paid to purchase stock under equity plans
acquisitions of noncontrolling interests
distributions to noncontrolling interests
conversion of notes to stock, net of unamortized issuance cost
equipment purchase contracts
noncontrolling interests in mmj
adjustment for primarily pre-petition liabilities
adjustment to gain on mmj acquisition
customer prepayments																																	-82,000,000	-59,000,000	212,000,000
cash paid to purchase common stock under equity plans
cash paid for capped call transactions
proceeds from issuance of common stock under equity plans																																	23,000,000	80,000,000	144,000,000
cash received from capped call transactions
effect of changes in currency exchange rates on cash and cash equivalents																																	2,000,000
adjustment to gain on acquisition of elpida
cash paid to purchase common stock																																		-31,000,000	-42,000,000
cash received from noncontrolling interests																																		0	49,000,000
noncash loss on restructure of debt																																			86,000,000
cash received for capped call transactions
effect on changes in foreign currency exchange rates on cash and cash equivalents																																			-19,000,000
loss on extinguishment of debt
gain from acquisition of elpida
change in operating assets and liabilities, net of amounts from elpida acquisition:
cash acquired from acquisition of elpida, net of cash paid
proceeds from sales of property, plant and equipment
return of equity method investment
noncontrolling interests in elpida:
gain on acquisition
gain from disposition of japan fab
gain from acquisition of numonyx
proceeds from sale of interest in hynix jv
cash acquired from acquisition of numonyx
cash (paid) received for capped call transactions
stock and restricted stock units issued in acquisition of numonyx
acquisition of interest in transform
for the year ended
net sales
net income attributable to micron
earnings per share:
basic
diluted
equity in net incomees of equity method investees, net of tax
provision to write-down inventories to estimated market values
restructure charges
(gain) income from disposition of property, plant and equipment
gain from inotera and hynix jv stock issuances
acquisition of noncontrolling interests in tech
decrease (increase) in restricted cash
cash paid to purchase capped calls
proceeds from debt
proceeds from issuance of common stock
consideration:
fair value of common stock issued
fair value of restricted stock units issued
recognized amounts of identifiable assets acquired and liabilities assumed:
depreciation and amortization
increase in receivables
increase in inventories
increase in accounts payable and accrued expenses
increase in customer prepayments
consolidation of tech
cash acquired from acquisition of lexar
capital contribution from noncontrolling interest in imft
proceeds from settlement of call spread options
proceeds from sale of noncontrolling interest in mp mask
proceeds from issuance of stock rights
redemption of common stock
cash and equivalents at beginning of year
cash and equivalents at end of year
stock and stock options issued in acquisition of lexar
investment securities
available-for-sale securities:
commercial paper
u.s. government and agencies
certificates of deposit
corporate notes and bonds
repurchase agreements
less cash equivalents
less noncurrent investments
short-term investments
noncash restructure and other charges
provision to write down inventories to estimated market values
gain from write-down or disposition of equipment
gain from write-down or disposition of investments
debt issuance costs
purchase of call spread options
net income, as reported
redeemable common stock accretion
redeemable common stock fair value adjustment
net income available to common shareholders
stock-based employee compensation expense included in reported net income, net of tax
less total stock-based employee compensation expense determined under a fair value-based method for all awards, net of tax
pro forma net income available to common shareholders
basic, as reported
basic, pro forma
diluted, as reported
diluted, pro forma

We provide you with 20 years of cash flow statements for Micron Technology . stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Micron Technology . stock. Explore the full financial landscape of Micron Technology . stock with our expertly curated income statements.

The information provided in this report about Micron Technology . stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.